Plasmid DNA transfection introduces exogenous DNA into mammalian cells so that a transgene can be expressed transiently or, with selection and genomic integration/maintenance strategies, stably. Chemical transfection reagents form complexes with DNA that promote uptake into cells. Efficiency depends strongly on cell line, confluence, DNA quality, reagent chemistry, DNA:reagent ratio and culture conditions.
This SOP is a general optimisation framework, not a substitute for the reagent-specific protocol. Always begin with the exact DNA and reagent amounts recommended for your transfection chemistry and plate format, then optimise systematically.
Experimental planning
- Use healthy, actively dividing cells and keep passage number consistent.
- Use high-quality, endotoxin-low plasmid DNA with verified sequence and concentration.
- Include untreated, mock/reagent-only and positive reporter controls.
- Optimise DNA amount and reagent amount independently rather than increasing both together.
- Assess both expression efficiency and viability/toxicity.
General transient transfection workflow
- Seed cells before transfection. Plate cells so they reach the confluence recommended for the reagent on the day of transfection. Many lipid/polymer protocols use roughly 60–90% confluence depending on reagent and cell line.
- Prepare DNA. Dilute plasmid DNA in the reagent's recommended serum-free or reduced-serum medium.
- Prepare transfection reagent separately. Dilute the reagent in the same compatible medium.
- Form complexes. Combine DNA and reagent gently and incubate for the reagent-specific complexation time, often approximately 10–20 minutes at room temperature.
- Add complexes to cells. Distribute evenly across the well without directly pipetting onto a small cell area.
- Incubate. Maintain cells under the reagent's recommended culture conditions. Some chemistries are compatible with serum and no medium change; others benefit from medium replacement after several hours.
- Assess expression. Reporter expression is commonly measured 24–72 hours after transfection depending on promoter, protein maturation and assay.
- Measure viability. Check morphology, cell count or an independent viability assay so low reporter signal is not mistaken for poor delivery when toxicity is the true cause.
Essential controls
- Untreated control: baseline cell health and autofluorescence.
- Mock control: transfection reagent without DNA; isolates reagent toxicity.
- Positive reporter plasmid: GFP, luciferase or another well-characterised construct to assess delivery efficiency.
- Experimental plasmid: the construct of interest.
- Optional empty-vector control: controls for vector backbone effects.
How to optimise
Cell density
Too few cells can increase toxicity, while over-confluent cells often transfect poorly. Establish a density window for the specific cell line.
DNA quantity
More DNA does not always increase expression and can worsen toxicity or innate immune responses. Titrate around the manufacturer's starting condition.
Reagent:DNA ratio
This ratio is one of the strongest determinants of delivery and toxicity. Use a small matrix experiment rather than changing one variable blindly.
Incubation and medium change
If cells become rounded or detach, shorten exposure to complexes or perform an earlier medium change if the reagent allows it.
Stable transfection
For stable cell-line generation, first determine the minimum selection-agent concentration that kills non-transfected cells using a kill curve. After transfection and recovery, apply selection and expand resistant populations or single-cell clones. Confirm transgene expression and genomic stability rather than relying on antibiotic resistance alone.
Troubleshooting
| Problem | Likely cause | What to try |
|---|---|---|
| Low reporter expression | Poor DNA quality, wrong cell density or suboptimal ratio | Verify plasmid, use a positive reporter and run a DNA:reagent optimisation matrix. |
| High toxicity | Too much reagent/DNA or prolonged exposure | Reduce reagent, lower DNA, shorten exposure or change medium earlier. |
| Good GFP but poor experimental protein | Construct/promoter/protein instability rather than delivery | Check sequence, transcript level and protein turnover/localisation. |
| Large well-to-well variation | Uneven seeding or complex distribution | Standardise cell counting, mixing and addition technique. |
| No stable colonies | Selection too early/strong or poor transfection | Run a kill curve, allow recovery and confirm transient delivery first. |
References and primary methods
- Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973;52:456–467. doi:10.1016/0042-6822(73)90341-3.
- Felgner PL et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A. 1987;84:7413–7417. doi:10.1073/pnas.84.21.7413.
- Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol. 1987;7:2745–2752. doi:10.1128/MCB.7.8.2745-2752.1987.
Measuring transfection efficiency properly
A positive reporter plasmid is the simplest way to distinguish delivery efficiency from construct-specific expression problems. For fluorescent reporters, flow cytometry can quantify the percentage of reporter-positive cells and per-cell intensity. Microscopy is useful for morphology and localisation but is less rigorous for population-level efficiency unless image analysis is standardised.
DNA quality requirements
- Confirm plasmid identity and insert sequence.
- Use a clean preparation with low endotoxin for sensitive mammalian cells.
- Check concentration with a suitable method rather than relying on an old nominal value.
- Avoid repeated freeze-thaw cycles.
- For large plasmids, expect lower delivery efficiency and optimise separately from small reporter plasmids.
Optimisation matrix
For a new cell line, a small matrix is more informative than a single-condition trial. Keep cell density constant and test two or three DNA amounts against two or three reagent amounts. Measure both reporter expression and viability. The best condition is not necessarily the one with the brightest signal; a slightly lower expression level with substantially better viability may produce more reproducible downstream biology.
Primary and difficult-to-transfect cells
Primary cells, stem cells and some suspension lines can respond poorly to conventional lipid/polymer transfection. Do not simply escalate reagent concentration because toxicity can rise faster than delivery. Nucleofection/electroporation or cell-type-specific reagents may be more appropriate. Optimisation should include viability 24–72 hours after delivery, not just early reporter expression.
Transient versus stable expression
- Transient transfection: fast and suitable for reporter assays, protein expression and short-term pathway experiments.
- Stable expression: requires selection, expansion and confirmation that expression remains stable over passages.
- Clonal lines: reduce population heterogeneity but can introduce clone-specific phenotypes; compare more than one clone when mechanism matters.
Selection-agent kill curves
Before generating a stable line, expose non-transfected cells to a concentration range of the intended antibiotic. Identify the lowest concentration that reliably eliminates the parental cells within a practical time window. Use that information to design selection rather than copying a concentration from another cell line.
Quality criteria for a transfection experiment
- Untreated control retains normal morphology and viability.
- Mock-transfected cells separate reagent toxicity from DNA effects.
- Positive reporter confirms the delivery system is functioning.
- Experimental plasmid expression is measured with an appropriate orthogonal readout such as western blot, qPCR or functional assay.
- Replicate wells show comparable cell density and expression.
Frequently asked questions
Why is transfection efficiency low even with a good reporter?
Cell density, passage history, DNA quality, complex ratio or reagent compatibility may be suboptimal. Optimise these variables systematically rather than increasing reagent alone.
Can antibiotics remain in the culture medium during transfection?
Some reagent protocols recommend antibiotic-free medium during complex exposure, while others tolerate antibiotics. Follow the reagent-specific instructions because compatibility differs.
When should I measure expression?
Many plasmid experiments are assessed at 24–72 hours, but timing depends on promoter activity, protein maturation, turnover and downstream assay.
Why does GFP look good but my target protein is absent?
The issue may be construct sequence, transcription, translation, protein instability or toxicity rather than delivery. Confirm mRNA and protein independently.
Explore more with ABMIUM
Planning expression, signalling or reporter validation after transfection? Use Find your MATCH for antibodies and recombinant proteins, or explore related ICC, western blot and In-Cell ELISA workflows.